Promega Corporation

BRK Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human BRK was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. BRK is a member of the non-receptor tyrosine kinases (PTKs) that contains an amino terminal SH3 and SH2 domain as well as the catalytic domain (1). BRK expression is low or undetectable in normal mammary tissue and benign lesions. However, approximately two-thirds of breast tumors express appreciable levels, and 27% of tumors over express BRK by fivefold or more (2).

ADP-Glo™ Kinase Assay is a luminescent kinase assay that measures ADP formed from a kinase reaction; ADP ...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega France only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
BRK Kinase Enzyme System
Close Window

BRK Kinase Enzyme System  Components

10μg
- V4054 € 364,00 Add to cart

BRK Kinase Enzyme System

Close Window

BRK Kinase Enzyme System

 Components

1mg
- V6276 € 5 610,00 Add to cart
ADP-Glo™ Kinase Assay + BRK Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + BRK Kinase Enzyme System  Components

  • BRK Kinase Enzyme System

    V40541 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4055 € 738,00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4054, V6276, V4055 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4055 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4055 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4055 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V4055 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4055 U.S. Pat. No. 8,183,007 and other patents pending.

V4055 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4055 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Prefer a different language?

Your country is set to France. Your language is set to français. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.